<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae</dc:title>
  <dc:creator>HAMMERSCHLAG, M. R</dc:creator>
  <dc:creator>ROBLIN, P. M</dc:creator>
  <dc:relation>International journal of antimicrobial agents -- Int. j. antimicrob. agents, ISSN 0924-8579, Vol. 15 (2) , pp. 149-152</dc:relation>
  <dc:date>2000</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:publisher>Elsevier</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>15 ref</dc:format>
  <dc:subject xml:lang="fr">Appareil respiratoire pathologie</dc:subject>
  <dc:subject xml:lang="fr">Bactérie</dc:subject>
  <dc:subject xml:lang="fr">Chlamydiaceae</dc:subject>
  <dc:subject xml:lang="fr">Chlamydiales</dc:subject>
  <dc:subject xml:lang="fr">Infection</dc:subject>
  <dc:subject xml:lang="fr">Poumon pathologie</dc:subject>
  <dc:subject xml:lang="fr">Activité biologique</dc:subject>
  <dc:subject xml:lang="fr">Antibactérien</dc:subject>
  <dc:subject xml:lang="fr">Bactériose</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Chlamydia pneumoniae</dc:subject>
  <dc:subject xml:lang="fr">Clarithromycine</dc:subject>
  <dc:subject xml:lang="fr">Concentration minimale bactéricide</dc:subject>
  <dc:subject xml:lang="fr">Concentration minimale inhibitrice</dc:subject>
  <dc:subject xml:lang="fr">Essai clinique</dc:subject>
  <dc:subject xml:lang="fr">Etude double insu</dc:subject>
  <dc:subject xml:lang="fr">Fluoroquinolone dérivé</dc:subject>
  <dc:subject xml:lang="fr">In vitro</dc:subject>
  <dc:subject xml:lang="fr">In vivo</dc:subject>
  <dc:subject xml:lang="fr">Macrolide</dc:subject>
  <dc:subject xml:lang="fr">Moxifloxacine</dc:subject>
  <dc:subject xml:lang="fr">Pneumonie</dc:subject>
  <dc:subject xml:lang="fr">Quinolone dérivé</dc:subject>
  <dc:subject xml:lang="fr">Randomisation</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Voie orale</dc:subject>
  <dc:subject xml:lang="en">Respiratory disease</dc:subject>
  <dc:subject xml:lang="en">Bacteria</dc:subject>
  <dc:subject xml:lang="en">Chlamydiaceae</dc:subject>
  <dc:subject xml:lang="en">Chlamydiales</dc:subject>
  <dc:subject xml:lang="en">Infection</dc:subject>
  <dc:subject xml:lang="en">Lung disease</dc:subject>
  <dc:subject xml:lang="en">Biological activity</dc:subject>
  <dc:subject xml:lang="en">Antibacterial agent</dc:subject>
  <dc:subject xml:lang="en">Bacteriosis</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Chlamydia pneumoniae</dc:subject>
  <dc:subject xml:lang="en">Clarithromycin</dc:subject>
  <dc:subject xml:lang="en">Minimum bactericidal concentration</dc:subject>
  <dc:subject xml:lang="en">Minimum inhibitory concentration</dc:subject>
  <dc:subject xml:lang="en">Clinical trial</dc:subject>
  <dc:subject xml:lang="en">Double blind study</dc:subject>
  <dc:subject xml:lang="en">Fluoroquinolone derivatives</dc:subject>
  <dc:subject xml:lang="en">In vitro</dc:subject>
  <dc:subject xml:lang="en">In vivo</dc:subject>
  <dc:subject xml:lang="en">Macrolide</dc:subject>
  <dc:subject xml:lang="en">Moxifloxacin</dc:subject>
  <dc:subject xml:lang="en">Pneumonia</dc:subject>
  <dc:subject xml:lang="en">Quinolone derivatives</dc:subject>
  <dc:subject xml:lang="en">Randomization</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Oral administration</dc:subject>
  <dc:subject xml:lang="es">Aparato respiratorio patología</dc:subject>
  <dc:subject xml:lang="es">Bacteria</dc:subject>
  <dc:subject xml:lang="es">Chlamydiaceae</dc:subject>
  <dc:subject xml:lang="es">Chlamydiales</dc:subject>
  <dc:subject xml:lang="es">Infección</dc:subject>
  <dc:subject xml:lang="es">Pulmón patología</dc:subject>
  <dc:subject xml:lang="es">Actividad biológica</dc:subject>
  <dc:subject xml:lang="es">Antibacteriano</dc:subject>
  <dc:subject xml:lang="es">Bacteriosis</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Chlamydia pneumoniae</dc:subject>
  <dc:subject xml:lang="es">Claritromicina</dc:subject>
  <dc:subject xml:lang="es">Concentración mínima bactericida</dc:subject>
  <dc:subject xml:lang="es">Concentración mínima inhibidora</dc:subject>
  <dc:subject xml:lang="es">Ensayo clínico</dc:subject>
  <dc:subject xml:lang="es">Estudio doble ciego</dc:subject>
  <dc:subject xml:lang="es">Fluoroquinolone derivado</dc:subject>
  <dc:subject xml:lang="es">In vitro</dc:subject>
  <dc:subject xml:lang="es">In vivo</dc:subject>
  <dc:subject xml:lang="es">Macrólido</dc:subject>
  <dc:subject xml:lang="es">Moxifloxacina</dc:subject>
  <dc:subject xml:lang="es">Neumonía</dc:subject>
  <dc:subject xml:lang="es">Quinolone derivado</dc:subject>
  <dc:subject xml:lang="es">Aleatorización</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject xml:lang="es">Vía oral</dc:subject>
  <dc:subject>002B02S02: Antibactériens / Antibacterial agents</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1386816</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>